Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Aptevo Therapeutics Inc. (APVO) had Free Cash Flow per Share of $-18.52 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.20M |
|
-- |
|
-- |
|
$6.23M |
|
$-6.23M |
|
$0.02M |
|
$-6.20M |
|
$-6.20M |
|
$-6.20M |
|
$-6.20M |
|
$-6.20M |
|
$-6.20M |
|
$-6.23M |
|
$-6.18M |
|
0.74M |
|
0.74M |
|
$-8.40 |
|
$-8.40 |
|
| Balance Sheet Financials | |
$11.08M |
|
$0.43M |
|
$4.54M |
|
$15.62M |
|
$4.89M |
|
-- |
|
$4.21M |
|
$9.10M |
|
$6.52M |
|
$6.52M |
|
$6.52M |
|
3.22M |
|
| Cash Flow Statement Financials | |
$-13.67M |
|
-- |
|
$14.36M |
|
$8.71M |
|
$9.41M |
|
$0.70M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-95.09% |
|
-95.10% |
|
-39.71% |
|
-95.09% |
|
$2.02 |
|
|
Free Cash Flow per Share |
$-18.52 |
$-18.52 |
|